Renasant Corporation (RNST) — Fair Value Analysis

Base-case fair value (P50): $28.97 · Current price: $43.55 · Verdict: Overvalued

The Verdict on RNST

Our latest Monte Carlo simulations indicate RENASANT CORP (RNST) is Deeply Overvalued at its current market price. With $43.55, the stock trades significantly above its median fair value (P50) of $28.97. This analysis suggests a substantial potential downside, with the stock needing to decline by -33.5% to reach its probabilistic fair value. Investors should take note of this considerable disparity, as our models, which account for thousands of forward scenarios, point to a strong overvaluation based on projected fundamentals.

How RNST stacks up against peers

While RENASANT CORP operates in a specific sector, its unrated quality tier implies we haven't yet assessed its operational and financial health relative to its peers. However, the quantitative output from our Monte Carlo fair value model provides a clear directional signal for RNST. Even without a comparative quality rating, the sheer magnitude of the -33.5% gap between $43.55 and the $28.97 fair value highlights a significant disconnect from its intrinsic value according to our simulations. This makes the overvaluation verdict particularly compelling, irrespective of an explicit peer comparison on qualitative metrics.

What this means for investors

For investors considering RENASANT CORP, the current market price of $43.55 presents a challenging proposition given the $28.97 median fair value and the -33.5% implied downside. Our simulations suggest that buying RNST at this level carries considerable risk from a valuation perspective. Even a less severe downside scenario would still imply a substantial correction from its current trading level. FairCurve subscribers can access the full bear and bull case distribution for RNST, including probability metrics, to gain a more granular understanding of potential outcomes. Sign up for FairCurve to see the full bear/bull distribution and track RNST's fair value as new fundamentals are released.

Frequently Asked Questions

Is RNST overvalued or undervalued right now?

Based on our Monte Carlo simulations, RENASANT CORP (RNST) is deeply overvalued. Its current price of $43.55 is significantly higher than its median fair value (P50) of $28.97.

What is the bear case and bull case for RNST?

The full Monte Carlo distribution, including bear (P10) and bull (P90) price targets, as well as the probability of upside or downside, is available to FairCurve account holders. We do not provide specific dollar values for these scenarios publicly.

How does FairCurve calculate RNST's fair value?

FairCurve calculates RNST's fair value using sophisticated Monte Carlo simulations, running thousands of forward-looking scenarios to determine a probabilistic range of intrinsic values based on projected fundamentals.

How can I track RNST's fair value as it changes?

You can add RNST to a free FairCurve watchlist to receive daily fair-value updates. FairCurve will instantly re-value the stock and notify you when new earnings or significant fundamental data are released.